Branded

WOONSOCKET, R.I. — CVS/pharmacy is teaming up with The Partnership at Drugree.org to create a community donation program through which local police departments can apply to receive a drug collection unit to help their communities safely dispose of unwanted medications, including controlled substances, the pharmacy retailer announced on Thursday.

NEW YORK — Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

The company that manufactures Cefaly expects to make the device available via select pharmacies and clinics in the months ahead. 

ZURICH — Novartis on Tuesday made a number of moves that have fundamentally reshaped its business, according to published reports. Novartis exchanged its vaccine business with GlaxoSmithKline in a deal valued at $7.1 billion for GSK's oncology portfolio (at a cost of $14.5 billion) and divested its animal health unit to Ely Lilly for approximately $5.4 billion. 

ARLINGTON, Va. — This week, 49 members of the U.S. House of Representatives urged Health and Human Services Secretary Kathleen Sebelius to adopt a one-year transition period for states to implement the July 2014 average manufacturer price-based federal upper limits. The National Association of Chain Drug Stores commended Reps. Mike Rogers, R-Mich., and Bruce Braley, D-Iowa, for leading the letter effort with their colleagues.

IRVINE, Calif. — Allergan on Tuesday confirmed that it has received an unsolicited proposal from Valeant Pharmaceuticals to acquire all of the outstanding shares of the company for a combination of 0.83 of Valeant common shares and $48.30 in cash per share of common stock of Allergan.

NEW YORK — ABC News will be hosting a live Twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat. ABC plans to cover a range of topics related to pain management, including chronic pain and palliative care.

To join in on the conversation, click here. 

BALTIMORE — Lupin on Monday announced the appointment of Theresa Stevens as chief corporate development officer for its global operations. Stevens will assume full responsibility for global merger and acquisitions and specialty business strategy. Stevens has more than 27 years of experience in the pharmaceutical and biotech sector, with significant experience in managing strategy, corporate development, M&A and licensing.    

LONDON — Pfizer is making a bid of $100.8 billion (£60 billion) for Astra Zeneca, according to a report in the Sunday Times, a U.K. daily, published Sunday. 

Citing insiders, the Sunday Times reported that, internally, Astra Zeneca is resisting the overture. 

"The New York company is keen to deploy a $70 billion (£42 billion) cash pile that it has accumulated in overseas subsidiaries," the paper reported.